Refer to a Hopkins Colleague

 

Continuing Medical Education

 

Case Rounds

 

Observerships & Visits

 

Videoconferences

 

Events and Seminars

 

Publications

 

Services for Your Institution

 

Medical News from Johns Hopkins

 

Contact Us


 

International Physician Update

OTOLARYNGOLOGY - HEAD & NECK SURGERY   
   



Treating Meniere's Disease

minorcarey190   
Special goggles worn by patient Harold Daniels help Lloyd Minor, left, and John Carey detect subtle eye movements that may signal recurrence of Meniere's.  
   
Harold Daniels was being hit by attacks of dizziness and nausea so bad that he would lie in bed for hours vomiting. “I was in a fog, exhausted, wanting to sleep,” says the 56-year- old software entrepreneur from Potomac, Maryland.  “I would get up and say I’m going to whip this thing. Then it would hit me again, like Muhammed Ali.”

Daniels’ curse was Meniere’s disease. The buildup of fluid in the inner ear that defines the miserable condition had ruptured the membranes of his inner ear, causing a perpetual ringing, hearing loss and intolerable vertigo.

Daniels got on the Internet and discovered several treatments. But most came with a worry. Surgery on the impaired inner-ear membranes could correct the condition, but posed a 5 percent risk of destroying remaining hearing. A drug called Gentamicin injected directly into the middle ear once a day for five days, or multiple times a day over two or three days, could control vertigo as effectively as surgery, but also posed the risk of further hearing loss.

Then Daniels discovered a third option. Lloyd Minor, M.D., and John Carey, M.D., at Hopkins also used Gentamicin. But these otolaryngologists were getting rid of the vertigo with just a single dose. And they had cut the risk of additional hearing loss to a minuscule 2 percent.

To come up with the new approach, Minor and Carey had studied how Gentamicin reacted on chinchillas. They found that the drug became sequestered within the impaired sensory cells in the animals’ middle ear. Weeks later, it went off like a time bomb and disabled the cells. Clinicians who tended to inject the drug were unaware of this delayed effect. Knowing how much to give had been a stab in the dark.

“Our research validated giving just a single injection,” Minor says. “We’re able to control the vertigo, and we haven’t had anyone lose hearing.” The regimen has proven effective in 90 percent of cases.
Daniels has not had a recurrence of vertigo or lost more hearing: “Dr. Minor walks on water. He’s given me back the quality of my life.”



 

 


More on Otolaryngology-Head and Neck Surgery...

 
Back to top
2006 | All Rights Reserved | Johns Hopkins University and Health System
601 North Caroline Street, Baltimore, Maryland 21287-0765 USA
Contact Us | Johns Hopkins Medicine